ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1861

Neurotrophins Are Involved In Vascular Remodeling Of Giant Cell Arteritis

Kim Heang Ly1,2, Alexis Régent3, Elsa Molina4, Sofiane Saada4, Philippe Sindou4, Claire Le Jeunne5, Antoine Brezin6, Veronique witko-Sarsat3, Philippe Bertin7, Francois Labrousse8, Pierre-Yves Robert9, Anne-Laure Fauchais10, Elisabeth Vidal10, Luc Mouthon11 and Marie-Odile Jauberteau4, 1CHU Dupuytren, Limoges, Limoges, France, 2Immunology Laboratory, EA3842, Limoges Medical school, Limoges, France, 3Institut Cochin, INSERM U1016, CNRS UMR 8104, Université Paris Descartes, Paris, France, 4Immunology Laboratory, EA 3842, Limoges Medical School, Limoges, France, 5Department of Internal Medicine, Hotel-Dieu Hospital, AP-HP, Paris, Paris, France, 6Service d’ophtalmologie, hôpital Cochin, AP-HP, Paris, France, 7Hôpital Dupuytren, Limoges, France, 8Department of Pathology, Limoges University Hospital, Limoges, France, 9Departement of Ophthalmology, Limoges University Hospital, Limoges, France, 10Department of Internal Medicine A, Dupuytren Hospital, Limoges University Hospital, Limoges, France, 11Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: giant cell arteritis, Inflammation, neuropeptides and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Giant cell arteritis (GCA) is a large-vessels vasculitis. Hhistopathological findings show cellular infiltrates, internal elastic lumina disruption and intimal hyperplasia leading to luminal stenosis. Platelet-derived growth factor (PDGF)  stimulates vascular smooth muscle cells (VSMC) migration from the media to the intima initiating intimal hyperplasia. Neurotrophins (NTs) and their receptors (NTRs) belong to a family of growth factors, described in nervous system. They include the nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3). NTR include: the selective tropomyosin receptor kinase (Trk), TrkA for NGF, TrkB for BDNF and TrkC for NT-3, and a non-selective receptor p75NTR and a co-receptor, which is almost associated with p75NTR, called sortilin. NTs and NTRs are involved in cardiovascular development, blood vessel growth and VSMC functions. We hypothesized that NTs and NTRs are involved in the vascular remodeling stage of GCA.

Methods: We included consecutive patients who underwent temporal artery biopsy (TAB) for a suspicion of GCA. We develop an enzymatic digestion method to obtain VSMC from TAB (TASMC). TASMC from six GCA patients and 10 controls were used to study NT and NTR involvement in vascular remodeling of GCA.

Results: NGF, BDNF and sortilin were significantly overexpressed in GCA patients (n=22) compared to controls (n=21). NT-3 and p75NTR were only expressed in GCA patients. An overexpression of TrkB receptor was noted in GCA patients with ischemic complications. NT-3, TrkB, TrkC and sortilin trancripts were overexpressed (increase upper fivefold levels) in TASMC from GCA patients compared to controls. NTs stimulated TASMC proliferation, similarly to FCS (10%) at day 3 in both groups, this effect tended to disappear at day 4. The p75NTR blocking alone tend to decrease cell proliferation at day 3, especially in GCA patients TASMC (p=0.053). TASMC from GCA patients were significantly able to migrate in presence of exogenous BDNF in comparison to those from controls after a 24-hour exposure. Only cells from GCA were able to significantly invade matrigel chambers in presence of 10% FCS and exogenous PDGF. NGF sera concentrations were significantly higher in 30 patients with proven GCA compared to 48 controls (177 +/- 67.6 pg/mL vs 145.5 +/- 66 pg/mL, p=0.04) .

Conclusion: Herein, we report for the first time, the expression and functions of NTs and their receptors, potentially involved in vascular remodelling in GCA. It is worth noting that NGF, BDNF and sortilin are significantly overexpressed in different histological layers of TA in GCA patients compared to those of controls. In addition, TrkB staining was significantly higher in TA of GCA patients with cranial ischemic events. BDNF enhances TASMC migration by binding to TrkB and p75NTR receptor. Our results provide new insight concerning NTs and their receptors in the vascular remodelling stage of GCA pathogenesis. Their overexpression could contribute to intimal hyperplasia by facilitating VSMC migration from media to intima. However further studies will be conducted to elucidate signalling pathways that allow VSMC migration in order to define new therapeutic approach in patients with GCA


Disclosure:

K. H. Ly,
None;

A. Régent,
None;

E. Molina,
None;

S. Saada,
None;

P. Sindou,
None;

C. Le Jeunne,
None;

A. Brezin,
None;

V. witko-Sarsat,
None;

P. Bertin,
None;

F. Labrousse,
None;

P. Y. Robert,
None;

A. L. Fauchais,
None;

E. Vidal,
None;

L. Mouthon,
None;

M. O. Jauberteau,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neurotrophins-are-involved-in-vascular-remodeling-of-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology